Skip to main content
Premium Trial:

Request an Annual Quote

Possibly as Transmissible

Officials in the UK say that the B.1.617.2 variant of SARS-CoV-2 may be transmitted as easily as or even more easily than the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Earlier this week, the World Health Organization classified the B.1.617 variant uncovered in India as a "variant of concern," based on preliminary findings that it may be more transmissible than other variants. B.1.617.2 is a sublineage of B.1.617, New Scientist notes, adding that there have been 520 cases in the UK tied to the variant.

It further reports that the University of Cambridge's Sharon Peacock said that Public Health England is moderately confident that the B.1.617.2 variant is at least as transmissible as the B.1.1.7 variant, which was itself found to be more transmissible than other variants.

The Guardian adds that a new, though small, analysis from the Real-time Assessment of Community Transmission (REACT) Study team observed the B.1.617.2 variant at a similar rate to the B.1.1.7 variant in London. "It seems to be circulating, at least in London, and it is at least as transmissible as the Kent [B.1.1.7] variant. We need to understand more about it," Paul Elliott, director of the REACT study at Imperial College London, tells it.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.